Keywords
Affiliated Institutions
Related Publications
Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US
Importance Active surveillance (AS) is endorsed by clinical guidelines as the preferred management strategy for low-risk prostate cancer, but its use in contemporary clinical pr...
Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations
Both the incidence of early-stage prostate cancer and rates of PSA screening have declined and coincide with 2012 USPSTF recommendation to omit PSA screening from routine primar...
The Role of Increasing Detection in the Rising Incidence of Prostate Cancer
The rapid diffusion of screening interventions that have the ability to detect latent asymptomatic disease leads to important concerns regarding costs and patient quality of lif...
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial
Screening for prostate cancer using prostate-specific antigen (PSA) reduces prostate cancer mortality but can lead to adverse outcomes. We aimed to compare a traditional screeni...
Screening for Prostate Cancer
For men aged 55 to 69 years, the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one and should include discussion of the potential ...
Publication Info
- Year
- 1998
- Type
- article
- Volume
- 9
- Issue
- 5
- Pages
- 519-527
- Citations
- 153
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1023/a:1008805718310